Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0MS5W
|
|||
Drug Name |
US9340511, 6
|
|||
Synonyms |
SCHEMBL522900; CHEMBL3902458; MHMUTVWPLKKCIN-UHFFFAOYSA-N; BDBM227557; US9340511, 6; 2-[4-hydroxy-1-methyl-6-(4-methoxy-phenoxy)-isoquinoline-3-carboxamido]acetic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H18N2O6
|
|||
Canonical SMILES |
CC1=C2C=CC(=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=C(C=C3)OC
|
|||
InChI |
1S/C20H18N2O6/c1-11-15-8-7-14(28-13-5-3-12(27-2)4-6-13)9-16(15)19(25)18(22-11)20(26)21-10-17(23)24/h3-9,25H,10H2,1-2H3,(H,21,26)(H,23,24)
|
|||
InChIKey |
MHMUTVWPLKKCIN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | HIF-prolyl hydroxylase 2 (HPH-2) | Target Info | Inhibitor | [1] |
Target's Patent Info | HIF-prolyl hydroxylase 2 (HPH-2) | Target's Patent Info | [1] | |
KEGG Pathway | HIF-1 signaling pathway | |||
Pathways in cancer | ||||
Renal cell carcinoma | ||||
Panther Pathway | Hypoxia response via HIF activation | |||
Pathway Interaction Database | HIF-2-alpha transcription factor network | |||
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha | ||||
HIF-1-alpha transcription factor network | ||||
Reactome | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha |
References | Top | |||
---|---|---|---|---|
REF 1 | Process for making isoquinoline compounds. US9340511. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.